John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 56,714 shares at $15.18 ($861K) on 2022-11-07, disclosed to the SEC on 2022-11-09.
Open-market sale of $861k KNSA by CHIEF MEDICAL OFFICER. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.18 | 28,357 | $430K | 50.0% |
| 2 | $15.18 | 28,357 | $430K | 50.0% |
| Total | $15.18 avg | 56,714 | $861K | 100% |
| Filing → |
| KNSA | SELL | 2025-11-04 | $6.1M | — | Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |